Chronic Acamprosate Eliminates the Alcohol Deprivation Effect While Having Limited Effects on Baseline Responding for Ethanol in Rats
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Acamprosate (calcium-acetyl homotaurinate) is a relatively new compound developed for the treatment of alcoholism and has been shown to be effective in attenuating relapse in human alcoholics. In the current study, the effects of this drug were further examined using an animal model of oral ethanol self-administration in a limited access paradigm. Male Wistar rats were trained to respond for ethanol (10% w/v) or water in a two-lever free-choice operant condition. Acute administration of acamprosate (400 mg/kg) reduced ethanol consumption and increased responding for water. Chronic administration of lower daily doses of acamprosate (100 and 200 mg/kg) blocked the increased ethanol consumption typically observed in rats after an imposed abstinence period. This effect of acamprosate was selective for ethanol, as responding for water was unaffected at any dose tested. These results with rats suggest a model by which to explore the mechanisms for anti-relapse effects of acamprosate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Experimental Design: Procedures for the Behavioral Sciences
Kirk, R. (2013) · doi:10.4135/9781483384733 · Cited by 8,539
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Samson, H. H. (1986) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1986.tb05120.x · Cited by 652
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Relapse prevention: introduction and overview of the model
Marlatt, G. A., & George, W. H. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb03867.x · Cited by 476
Relapse Prevention: Introduction and Overview of the Model
Marlatt, G. A., & George, W. H. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb00274.x · Cited by 475
WOLFFGRAMM, J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00131-c · Cited by 331
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
Whitworth, A. B., Oberbauer, H., Fleischhacker, W. W., Lesch, O. M., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 320
"Craving" and Relapse to Drink
Ludwig, A. M., & Wikler, A. (1974) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1974.35.108 · Cited by 317
Cited by
Alcoholism: Allostasis and Beyond
Koob, G. F. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000057122.36127.c2 · Cited by 737
Neuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Metadata
- Authors
- Heyser, C.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Heyser, C
- ORCID
- Heyser, C
- Venue
- Neuropsychopharmacology
- Published
- 1998-02
- Volume
- 18
- Issue
- 2
- Pages
- 125-133
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2089237550
- Cited by
- 176
- References
- 46
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 4
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32aa005403-01)
- National Institute on Alcohol Abuse and Alcoholism (F32 AA05403, AA-06420, AA 07456, AA-08459)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- acamprosate, alcohol deprivation, ethanol self-administration, alcoholism treatment, alcohol withdrawal, ethanol consumption, alcoholism pharmacotherapy
- MeSH terms
- Acamprosate, Alcohol Deterrents, Alcohol Drinking, Ethanol, Animals, Central Nervous System Depressants, Conditioning, Operant, Dose-Response Relationship, Drug, Male, Substance Withdrawal Syndrome, Taurine, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Acamprosate Eliminates the Alcohol Deprivation Effect While Having Limited Effects on Baseline Responding for Ethanol in Rats. https://app.cochat.ai/papers/10.1016/s0893-133x(97)00130-9
- The paper
- Heyser, C. (1998). Chronic Acamprosate Eliminates the Alcohol Deprivation Effect While Having Limited Effects on Baseline Responding for Ethanol in Rats. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(97)00130-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.